Board of Directors

<!DOCTYPE html> <html lang="en" dir="ltr" prefix="og: https://ogp.me/ns#"> <head> <meta charset="utf-8" /> <link rel="canonical" href="https://investor.iconplc.com/corporate-governance/board-of-directors/" /> <meta property="og:site_name" content="ICON plc" /> <meta property="og:type" content="website" /> <meta property="og:url" content="https://investor.iconplc.com/corporate-governance/board-of-directors" /> <meta property="og:title" content="Board of Directors | ICON plc" /> <meta property="og:description" content="The Investor Relations website contains information about ICON plc's business for stockholders, potential investors, and financial analysts." /> <meta name="Generator" content="Drupal 10 (https://www.drupal.org)" /> <meta name="MobileOptimized" content="width" /> <meta name="HandheldFriendly" content="true" /> <meta name="viewport" content="width=device-width, initial-scale=1.0" /> <link rel="icon" href="/sites/g/files/knoqqb32306/files/favicons.png" type="image/png" /> <link rel="alternate" hreflang="en" href="https://investor.iconplc.com/corporate-governance/board-of-directors" /> <title>Board of Directors | ICON plc</title> <link rel="stylesheet" media="all" href="/sites/g/files/knoqqb32306/files/css/css_U1FIcCbp-W4dg7tJ1NFgPyywZAAW4ydEXMrNV3ViSpk.css?delta=0&language=en&theme=nir_pid2802&include=eJyVkGFqwzAMhS8U4tFfu0ZPIGRbtCa2VGRla29f1RkbgRZWDLb0-B5-EheFtFAuJgoZzU-s1MNfObEjDXUhGwDEKmkJjZBBKUlrxK4XYUhnVHvBI2O9dQN1lE8QUd_AO4wsG7tWK80TY9i3U3cDtRCxb-SjGExJwn0vmUj1DEO8lHz4_DgE-SLVkmlSzOUKFW-yWg-7bhi-KfZiBCxWki_riTb_vC_Ge6rOj2Ui57c83fw-rmLbzGNv_vMW6rebMUskH2LldP4HeFHJd9S51dg" /> <link rel="stylesheet" media="all" href="/sites/g/files/knoqqb32306/files/css/css_sZwKOXxwiWA9w7EU02RUifhR9PgaCZZBvDfftp_2LW4.css?delta=1&language=en&theme=nir_pid2802&include=eJyVkGFqwzAMhS8U4tFfu0ZPIGRbtCa2VGRla29f1RkbgRZWDLb0-B5-EheFtFAuJgoZzU-s1MNfObEjDXUhGwDEKmkJjZBBKUlrxK4XYUhnVHvBI2O9dQN1lE8QUd_AO4wsG7tWK80TY9i3U3cDtRCxb-SjGExJwn0vmUj1DEO8lHz4_DgE-SLVkmlSzOUKFW-yWg-7bhi-KfZiBCxWki_riTb_vC_Ge6rOj2Ui57c83fw-rmLbzGNv_vMW6rebMUskH2LldP4HeFHJd9S51dg" /> <link rel="stylesheet" media="all" href="/sites/g/files/knoqqb32306/themes/site/nir_pid2802/dist/css/foundation.css?snc0ge" /> <link rel="stylesheet" media="all" href="/sites/g/files/knoqqb32306/themes/site/nir_pid2802/dist/css/foundation-icons.css?snc0ge" /> <link rel="stylesheet" media="all" href="/sites/g/files/knoqqb32306/themes/site/nir_pid2802/dist/css/theme-jic-01.css?snc0ge" /> <link rel="stylesheet" media="all" href="//fonts.googleapis.com/css?family=Lato:400,400italic,700,300italic" /> <link rel="stylesheet" media="all" href="//fonts.googleapis.com/css?family=Lora:400,400italic,700,700italic" /> <link rel="stylesheet" media="all" href="/sites/g/files/knoqqb32306/themes/site/nir_pid2802/dist/css/font-awesome.min.css?snc0ge" /> <link rel="stylesheet" media="all" href="/sites/g/files/knoqqb32306/themes/site/nir_pid2802/dist/css/ndq-icons.css?snc0ge" /> <link rel="stylesheet" media="print" href="/sites/g/files/knoqqb32306/themes/site/nir_pid2802/css/print.css?snc0ge" /> <link rel="stylesheet" media="all" href="/sites/g/files/knoqqb32306/themes/site/nir_pid2802/css/ndq-newswires.css?snc0ge" /> <link rel="stylesheet" media="all" href="/sites/g/files/knoqqb32306/themes/site/nir_pid2802/css/chosen/chosen-admin.css?snc0ge" /> <link rel="stylesheet" media="all" href="/sites/g/files/knoqqb32306/themes/site/nir_pid2802/css/ndq-bootstrap-grid.css?snc0ge" /> <link rel="stylesheet" media="all" href="/sites/g/files/knoqqb32306/themes/site/nir_pid2802/css/ndq-widgets.css?snc0ge" /> <link rel="stylesheet" media="all" href="/sites/g/files/knoqqb32306/themes/site/nir_pid2802/css/site-specific.css?snc0ge" /> <link rel="stylesheet" media="all" href="/sites/g/files/knoqqb32306/themes/site/nir_pid2802/css/footer.css?snc0ge" /> <script src="/core/assets/vendor/modernizr/modernizr.min.js?v=3.11.7"></script> <script src="/sites/g/files/knoqqb32306/files/js/js_czWNosc4hBAdS7_MQt-bN35IY3-yYchyz4fd3xnCUwo.js?scope=header&delta=1&language=en&theme=nir_pid2802&include=eJyVkGFqwzAMhS8U4tFfu0ZPIGRbtCa2VGRla29f1RkbgRZWDLb0-B5-EheFtFAuJgoZzU-s1MNfObEjDXUhGwDEKmkJjZBBKUlrxK4XYUhnVHvBI2O9dQN1lE8QUd_AO4wsG7tWK80TY9i3U3cDtRCxb-SjGExJwn0vmUj1DEO8lHz4_DgE-SLVkmlSzOUKFW-yWg-7bhi-KfZiBCxWki_riTb_vC_Ge6rOj2Ui57c83fw-rmLbzGNv_vMW6rebMUskH2LldP4HeFHJd9S51dg"></script>  <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start': new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0], j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src= 'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f); })(window,document,'script','dataLayer','GTM-5K68HBC');</script>   <script src="https://cdn.cookielaw.org/scripttemplates/otSDKStub.js" type="text/javascript" charset="UTF-8" data-domain-script="32cc7b51-01e1-41c5-9582-c0b1c4c44433" ></script> <script type="text/javascript"> function OptanonWrapper() { } </script>  </head> <body class="body-sidebars-none nir-node nir-node--type-nir-landing-page nir-node--5841 path-node page-node-type-nir-landing-page"> <div id="skip"> <a class="visually-hidden focusable skip-link" href="#main-menu"> Skip to main navigation </a> </div> <div class="dialog-off-canvas-main-canvas" data-off-canvas-main-canvas> <div class="field field--name-field-nir-global-block-body field--type-text-long field--label-hidden field__item"><div class="global-block-content title-bar" data-responsive-toggle="investor-relations" data-hide-for="medium"> <button class="menu-icon" type="button" data-toggle></button> <div class="title-bar-title"><span style="display: none !important;"> </span></div> <div class="top-bar-center"> <a href="http://www.iconplc.com/"> <img src="/sites/g/files/knoqqb32306/themes/site/nir_pid2802/dist/img/ICON_positive_logo.svg"> </a> <div class="top-bar-arrow-down"><span style="display: none !important;"> </span></div> </div> </div></div> <div class="field field--name-field-nir-global-block-body field--type-text-long field--label-hidden field__item"><div class="global-block-content top-bar logo-container"> <div class="row"> <div class="show-for-medium top-bar-center"> <a href="http://www.iconplc.com/"> <img src="/sites/g/files/knoqqb32306/themes/site/nir_pid2802/dist/img/ICON_positive_logo.svg"> </a> <div class="top-bar-arrow-down"><span style="display: none !important;"> </span></div> </div> </div> </div></div> <div class="top-bar" id="investor-relations"> <div class="row"> <div class="global-block-content top-bar logo-container logo_top_header"> <div class="row"> <div class="show-for-medium top-bar-center"><a href="http://www.iconplc.com/"><img src="sites/g/files/knoqqb32306/themes/site/nir_pid2802/dist/img/ICON_positive_logo.svg" /> </a> <div class="top-bar-arrow-down"><span style="display: none !important;"> </span></div> </div> </div> </div> <div class="top-bar-left float-right"> <ul class="menu vertical medium-horizontal medium-text-left dropdown" data-responsive-menu="drilldown medium-dropdown"> <li class="levelOneNoChildren"> <a target="" href="https://www.iconplc.com/">Home</a> </li> <li class="levelOneNoChildren"> <a target="" href="/">Investors</a> </li> <li class="levelOneWithChildren has-submenu"> <a target="" href="/stock-information">Stock</a> <ul class="submenu menu vertical" data-submenu data-responsive-menu="accordion"> <li class="levelTwoNoChildren"> <a target="" href="/stock-information/stock-quote-chart">Stock Quote & Chart</a> </li> <li class="levelTwoNoChildren"> <a target="" href="/stock-information/ownership-profile">Ownership Profile</a> </li> <li class="levelTwoNoChildren"> <a target="" href="/stock-information/historic-stock-lookup">Historic Stock Lookup</a> </li> <li class="levelTwoNoChildren"> <a target="" href="/stock-information/investment-calculator">Investment Calculator</a> </li> <li class="levelTwoNoChildren"> <a target="" href="/stock-information/key-ratios">Key Ratios</a> </li> <li class="levelTwoNoChildren"> <a target="" href="/stock-information/dividend-history">Dividend History</a> </li> </ul> </li> <li class="levelOneNoChildren"> <a target="" href="/investor-releases">Recent News</a> </li> <li class="levelOneWithChildren has-submenu"> <a target="" href="/financials-filings">Financials</a> <ul class="submenu menu vertical" data-submenu data-responsive-menu="accordion"> <li class="levelTwoNoChildren"> <a target="" href="/financials-filings/financial-information">Financial Information</a> </li> <li class="levelTwoNoChildren"> <a target="" href="/financials-filings/sec-filings">SEC Filings</a> </li> <li class="levelTwoNoChildren"> <a target="" href="/financials-filings/quarterly-results">Quarterly Results</a> </li> <li class="levelTwoNoChildren"> <a target="" href="/financials-filings/annual-reports">Annual Reports</a> </li> <li class="levelTwoNoChildren"> <a target="" href="/financials-filings/proxy-materials">Proxy Materials</a> </li> </ul> </li> <li class="levelOneNoChildren"> <a target="" href="/events-presentations">Events</a> </li> <li class="levelOneWithChildren has-submenu active-levelOneWithChildren"> <a target="" href="/corporate-governance">Governance</a> <ul class="submenu menu vertical" data-submenu data-responsive-menu="accordion"> <li class="levelTwoNoChildren active-levelTwoNoChildren"> <a target="" href="/corporate-governance/board-of-directors">Board of Directors</a> </li> <li class="levelTwoNoChildren"> <a target="" href="https://www.iconplc.com/about/leadership">Executive Management</a> </li> <li class="levelTwoNoChildren"> <a target="" href="/corporate-governance/articles-committee-charters">Articles & Committee Charters</a> </li> <li class="levelTwoNoChildren"> <a target="" href="/corporate-governance/committee-composition">Committee Composition</a> </li> <li class="levelTwoNoChildren"> <a target="" href="/corporate-governance/governance-documents">Governance Documents</a> </li> </ul> </li> <li class="levelOneWithChildren has-submenu"> <a target="" href="/investor-resources">Resources</a> <ul class="submenu menu vertical" data-submenu data-responsive-menu="accordion"> <li class="levelTwoNoChildren"> <a target="" href="https://www.iconplc.com/about/esg">ESG</a> </li> <li class="levelTwoNoChildren"> <a target="" href="/investor-resources/faqs">FAQs</a> </li> <li class="levelTwoNoChildren"> <a target="" href="/investor-resources/analyst-coverage">Analyst Coverage</a> </li> <li class="levelTwoNoChildren"> <a target="" href="/investor-contact">Investor Contact</a> </li> <li class="levelTwoNoChildren"> <a target="" href="/email-alerts">Email Alerts</a> </li> </ul> </li> </ul> </div> <div class="top-bar-right"> <div class="small-12 columns"> <button data-open="searchModal" type="button" class="button" aria-label="Submit seach entry"></button> </div> </div> </div> </div> <div class="banner"> <div class="row"> <div class="medium-12 large-12 columns"> <ul class="slides"> <li class="slide-item"> <h1 class="banner-header"> Board of Directors </h1> </li> </ul> </div> <div class="show-for-medium medium-4 large-4 columns"> <div class="stock-quote"> <div id="block-stockquote" data-storage-id="node:5876:flexible_layout" class="block--market-data-block__stock-quote block--market-data-block__stock-quote--5876 block--banner-stockchart-desktop--market-data-block__stock-quote block--banner-stockchart-desktop--market-data-block__stock-quote--5876 block--b0606250-7621-4e51-a41c-8d975862d311 block--b0606250-7621-4e51-a41c-8d975862d311--5876 block block-nir-market-data-block block-market-data-block__stock-quote"> <div class='stock-quote stock-quote__short'> <div class="quote-wrapper"> <span class="exchange_nd_symbol"> </span> <span class=""></span> <span class=""></span> </div> </div> </div> </div> </div> </div> </div> <div class="row banner-chart-mobile"> <div class="expanded hide-for-medium medium-12"> <div class="stock-chart"> <div id="block-stockquote-2" data-storage-id="node:5876:flexible_layout" class="block--market-data-block__stock-quote block--market-data-block__stock-quote--5876 block--banner-stockchart-mobile--market-data-block__stock-quote block--banner-stockchart-mobile--market-data-block__stock-quote--5876 block--26ab812a-2872-4829-9341-37455b2fe8f0 block--26ab812a-2872-4829-9341-37455b2fe8f0--5876 block block-nir-market-data-block block-market-data-block__stock-quote"> <div class='stock-quote stock-quote__short'> <div class="quote-wrapper"> <span class=""></span> <span class=""></span> </div> </div> </div> </div> </div> </div> <br/> <div id="ndq-content" class="row ndq-5841"> <div id="block-nir-pid2802-websitenoticeblock" class="block--website-notice-block block--website-notice-block--5841 block--content--website-notice-block block--content--website-notice-block--5841 block--c17bf3cb-d490-44d7-8498-430bdd7f70b7 block--c17bf3cb-d490-44d7-8498-430bdd7f70b7--5841 block block-nir-website-notices block-website-notice-block"> </div> <div data-drupal-messages-fallback class="hidden"></div> <div id="block-nir-pid2802-content" class="block--system-main-block block--system-main-block--5841 block--content--system-main-block block--content--system-main-block--5841 block--5880c658-dabe-49f6-8f0c-e393965613d2 block--5880c658-dabe-49f6-8f0c-e393965613d2--5841 block block-system block-system-main-block"> <article class="node node--type-nir_landing_page node--view-mode-full clearfix"> <h1> Board of Directors </h1> <div> <div class="large-12 columns"> <div class="mb30"><div class="block-region-contentmain"> <div class="block--nir-people__widget block--nir-people__widget--5841 block--contentmain--nir-people__widget block--contentmain--nir-people__widget--5841 block--78157491-d18c-4335-ac53-bcd55eca38ec block--78157491-d18c-4335-ac53-bcd55eca38ec--5841 block block-nir-person block-nir-people__widget"> <div class="nir-widget"> <div class="nir-widget--content"> <div class="nir-widget--list"> <div class="persons"> <div class="person"> <div class="person__heading"> <img class="person__picture" height="120" src="/static-files/c0b03d77-aea9-440f-86d5-d99367aff591" width="120"> <div class="person__details"> <h3>Mr. Ciaran Murray</h3> <div class="field field--name-field-nir-person-title field--type-string field--label-hidden field__item">Chairman</div> </div> </div> <div class="person__body"> <div class="field field--name-field-nir-person-bio field--type-text-long field--label-hidden field__item"><p style="margin:0cm;margin-bottom:.0001pt"><a name="_GoBack"></a></p> <p style="margin:0cm;margin-bottom:.0001pt"><a name="_GoBack"></a></p> <p class="text-align-justify">Mr. Ciaran Murray graduated with a Bachelor of Commerce degree from University College Dublin in 1982. Mr. Murray subsequently qualified as a chartered accountant with PwC. Following qualification, Mr. Murray gained extensive global experience working as an executive in the fast moving consumer goods and technology sectors in Ireland, Italy, the UK and the US.</p> <p class="text-align-justify">Mr. Murray has been the Chair of ICON plc since March 2017. Mr. Murray served as Chief Executive Officer from October 2011 until March 2017 and was Chief Financial Officer from joining ICON plc in 2005 until his appointment as Chief Executive Officer in 2011.</p> <p class="text-align-justify">During his time with ICON plc, Mr. Murray was recognized for his leadership of ICON and the CRO industry. Mr. Murray served as Chair of the Association of Clinical Research Organizations (ACRO) which represents the CRO industry globally. In addition, Mr. Murray was named as a leader in CRO Innovation by PharmaVOICE100, a listing of the most influential people in the bio pharma industry.</p> <p class="text-align-justify">University College Dublin awarded Mr. Murray an honorary degree of Doctor of Laws in 2013 for his support of third level research and innovation in Ireland. In 2018, the Royal Dublin Society awarded Mr. Murray the RDS Gold Medal for Enterprise for making an exceptional impact on Irish industry and commerce. Mr. Murray is also a member of the advisory Board of UCD Smurfit Business School.</p></div> <div class="nir-widget--field nir-widget--person--dir-details"> <div class="nir-widget--list-item nir-widget--person--dir-detail ndqicon__independent">Independent Director</div><div class="nir-widget--list-item nir-widget--person--dir-detail ndqicon__chair">Chairman of the Board</div> </div> <div class="nir-widget--field nir-widget--person--committees"> </div> </div> </div><div class="person"> <div class="person__heading"> <img class="person__picture" height="120" src="/static-files/1861f3ac-304b-4225-b36c-b6d25f196d71" width="120"> <div class="person__details"> <h3>Dr. Steve Cutler</h3> <div class="field field--name-field-nir-person-title field--type-string field--label-hidden field__item">Chief Executive Officer</div> </div> </div> <div class="person__body"> <div class="field field--name-field-nir-person-bio field--type-text-long field--label-hidden field__item"><div> <p class="MsoNormal"><span lang="EN-IE">Dr. Steve Cutler was appointed Chief Executive Officer of ICON plc in March 2017, having previously served as Chief Operating Officer from January 2014. Dr. Cutler served as Group President of Clinical Research Services since November 2011 until his appointment as Chief Operating Officer. Dr. Cutler was appointed to the Board of ICON plc in November 2015. </span></p> <p class="MsoNormal"><span lang="EN-IE">Prior to joining the Company, Dr. Cutler held the position of Chief Executive Officer of Kendle, having previously served as Chief Operating Officer. Prior to Kendle, Dr. Cutler spent 14 years with Quintiles where he served as Senior Vice President, Global Project Management; Senior Vice President, Clinical, Medical and Regulatory; Senior Vice President, Project Management - Europe; and Vice President, Oncology - Europe, as well as regional leadership positions in South Africa and Australia. Prior to joining Quintiles, Dr. Cutler held positions with Sandoz (now Novartis) in Australia and Europe. </span></p> <p class="MsoNormal"><span lang="EN-IE">Dr. Cutler holds a B.Sc. and a Ph.D from the University of Sydney and a Masters of Business Administration from the University of Birmingham (UK).</span></p> </div></div> <div class="nir-widget--field nir-widget--person--committees"> <div class="nir-widget--list-item nir-widget--person--committee chairperson"><span class="nir-widget--person--committee-icon ndqicon__chairperson"></span><a href="/static-files/1459d44f-eb5d-45d5-860f-b98484dd1a29" target="_blank">Chair of the Execution Sub-Committee</a></div> </div> </div> </div><div class="person"> <div class="person__heading"> <img class="person__picture" height="120" src="/static-files/90e643d5-88a3-49aa-9620-1f2cec38c957" width="120"> <div class="person__details"> <h3>Mr. R贸n谩n Murphy</h3> <div class="field field--name-field-nir-person-title field--type-string field--label-hidden field__item">Non-Executive Director</div> </div> </div> <div class="person__body"> <div class="field field--name-field-nir-person-bio field--type-text-long field--label-hidden field__item"><p>Mr. R贸n谩n Murphy has served as a Non-Executive Director of ICON plc since October 2016. He was appointed as Lead Independent Director in January 2019. </p> <p>Mr. Murphy is the former Senior Partner of PwC Ireland. He was elected Senior Partner in 2007 and was re-elected for a further four year term in 2011. Following completion of the maximum two terms, Mr. Murphy retired from the firm in 2015. Mr. Murphy was also a member of the PwC EMEA Leadership Board for a five year period from 2010 to 2015. Mr. Murphy joined PwC in 1980 and was admitted to the Partnership in 1992.</p> <p>Mr. Murphy is presently Chair of Greencoat Renewables PLC. Mr. Murphy previously served as a council member of the ESRI, as Chair of Business in the Community Ireland and as a Non-Executive Director of Davy Stockbrokers. He is also a founding Board Member of the British Irish Chamber of Commerce. Mr. Murphy completed a Bachelor of Commerce and Masters in Business Studies at University College Dublin before qualifying as a chartered accountant in 1982.</p></div> <div class="nir-widget--field nir-widget--person--dir-details"> <div class="nir-widget--list-item nir-widget--person--dir-detail ndqicon__independent">Independent Director</div><div class="nir-widget--list-item nir-widget--person--dir-detail ndqicon__leaddir">Lead Director</div> </div> <div class="nir-widget--field nir-widget--person--committees"> <div class="nir-widget--list-item nir-widget--person--committee chairperson"><span class="nir-widget--person--committee-icon ndqicon__chairperson"></span><a href="/static-files/25717254-e23e-4e81-af2b-0963e84e416e" target="_blank">Chair of the Audit Committee</a></div><div class="nir-widget--list-item nir-widget--person--committee member"><span class="nir-widget--person--committee-icon ndqicon__member"></span><a href="/static-files/a4f3ff93-e1e8-4bf7-a6d1-180534cc2fcd" target="_blank">Member of the Compensation and Organisation Committee</a></div><div class="nir-widget--list-item nir-widget--person--committee member"><span class="nir-widget--person--committee-icon ndqicon__member"></span><a href="/static-files/1459d44f-eb5d-45d5-860f-b98484dd1a29" target="_blank">Member of the Execution Sub-Committee</a></div> </div> </div> </div><div class="person"> <div class="person__heading"> <img class="person__picture" height="120" src="/static-files/ee7889ac-8b8b-4d02-ae7c-55fe41955d86" width="120"> <div class="person__details"> <h3>Dr. John Climax</h3> <div class="field field--name-field-nir-person-title field--type-string field--label-hidden field__item">Non-Executive Director</div> </div> </div> <div class="person__body"> <div class="field field--name-field-nir-person-bio field--type-text-long field--label-hidden field__item"><p>Dr. John Climax, one of the ICON's co-founders, served as Chair of the Board of ICON plc from November 2002 to December 2009 and as Chief Executive Officer from June 1990 to October 2002. Since January 2010 he has held a position as a Non-Executive Director of ICON plc. Dr. Climax has over 30 years of experience in the clinical research industry.</p> <p>Dr. Climax received his primary degree in pharmacy in 1977 from the University of Singapore, his masters in applied pharmacology in 1979 from the University of Wales and his Ph.D. in pharmacology from the National University of Ireland in 1982. He has authored a significant number of papers and presentations, and holds adjunct professorship at the Royal College of Surgeons of Ireland and an honorary professorship at the National University of Singapore. He is currently Executive Chair of DS Biopharma and CEO of Afimmune, both of which are private companies.</p></div> <div class="nir-widget--field nir-widget--person--dir-details"> <div class="nir-widget--list-item nir-widget--person--dir-detail ndqicon__independent">Independent Director</div> </div> <div class="nir-widget--field nir-widget--person--committees"> </div> </div> </div><div class="person"> <div class="person__heading"> <img class="person__picture" height="120" src="/static-files/85a26d86-3c4c-4bb6-b992-885f35dfda24" width="120"> <div class="person__details"> <h3>Mr. Eugene McCague</h3> <div class="field field--name-field-nir-person-title field--type-string field--label-hidden field__item">Non-Executive Director</div> </div> </div> <div class="person__body"> <div class="field field--name-field-nir-person-bio field--type-text-long field--label-hidden field__item"><p>Mr. Eugene McCague was appointed as a Non-Executive Director of ICON plc in October 2017.</p> <p>Mr. McCague was a corporate partner of Arthur Cox, one of Ireland鈥檚 premier law firms, from 1988 until June 2017. During his time with Arthur Cox, Mr. McCague served as both managing partner and Chair of Arthur Cox and also advised a wide range of public and private companies on mainstream corporate work, mergers and acquisitions, corporate restructurings and corporate governance. In addition to his distinguished legal career, Mr. McCague also has extensive board experience with commercial, government and educational organizations.</p> <p>Mr. McCague currently serves on the board of the Irish branch of AON Insurance and he also serves as Chair of Ibec, Ireland鈥檚 leading business representative association. Mr. McCague鈥檚 previous board roles include the Health Service Executive, the Irish state body which administers public health service in Ireland, Chair of the governing body of the Dublin Institute of Technology, Chair of the Dublin Institute of Technology Foundation and Chair of the governing authority of University College Dublin and director of Fly Leasing Limited. Mr. McCague was also president of the Dublin Chamber of Commerce in 2006.</p> <p>Mr. McCague holds a Bachelor of Civil Law degree and a diploma in European Law from University College Dublin.</p></div> <div class="nir-widget--field nir-widget--person--dir-details"> <div class="nir-widget--list-item nir-widget--person--dir-detail ndqicon__independent">Independent Director</div> </div> <div class="nir-widget--field nir-widget--person--committees"> <div class="nir-widget--list-item nir-widget--person--committee member"><span class="nir-widget--person--committee-icon ndqicon__member"></span><a href="/static-files/25717254-e23e-4e81-af2b-0963e84e416e" target="_blank">Member of the Audit Committee</a></div><div class="nir-widget--list-item nir-widget--person--committee chairperson"><span class="nir-widget--person--committee-icon ndqicon__chairperson"></span><a href="/static-files/99ff596c-3662-4799-b32f-4351318b23b4" target="_blank">Chair of the Nominating, Sustainability & Governance Committee </a></div> </div> </div> </div><div class="person"> <div class="person__heading"> <img class="person__picture" height="120" src="/static-files/68ff3602-6fec-4c60-a280-6a23684f8188" width="120"> <div class="person__details"> <h3>Ms. Julie O'Neill</h3> <div class="field field--name-field-nir-person-title field--type-string field--label-hidden field__item">Non-Executive Director </div> </div> </div> <div class="person__body"> <div class="field field--name-field-nir-person-bio field--type-text-long field--label-hidden field__item"><p class="MsoNormal"><span lang="EN" style="mso-ansi-language:EN">Ms. Julie O鈥橬eill has served as a Non-Executive Director of ICON plc since July 2019. </span></p> <p class="MsoNormal"><span lang="EN" style="mso-ansi-language:EN">Ms. O鈥橬eill was formerly Executive Vice President, Global Operations of Alexion Pharmaceuticals, Inc., where she was responsible for global manufacturing operations and expanding and improving supply chain and quality operations in the US, Europe, and Asia. Before joining Alexion, Ms. O鈥橬eill was Vice President of Operations and General Manager for Ireland at Gilead Sciences and earlier in her career, Ms. O'Neill held leadership positions in operations, manufacturing and quality functions at Burnil Pharmacies and Helsinn Birex Pharmaceuticals. </span></p> <p class="MsoNormal"><span lang="EN" style="mso-ansi-language:EN"></span></p> <p>Ms. O鈥橬eill serves as a Board Member of DBV Technologies, Hookipa Pharma Inc., ILC Dover, Achilles Therapeutics plc and Advancion (formerly Angus Chemical Company). She also chairs the board of Ireland鈥檚 National Institute for Bioprocessing Research and Training.</p> <p>Ms. O鈥橬eill holds a Bachelor of Science in Pharmacy from Trinity College Dublin, a Masters of Business Administration from University College Dublin and is a Chartered Director of The Institute of Directors in Ireland. </p> <p class="MsoNormal"><span lang="EN" style="mso-ansi-language:EN"></span><span lang="EN" style="mso-ansi-language:EN"></span></p></div> <div class="nir-widget--field nir-widget--person--dir-details"> <div class="nir-widget--list-item nir-widget--person--dir-detail ndqicon__independent">Independent Director</div> </div> <div class="nir-widget--field nir-widget--person--committees"> <div class="nir-widget--list-item nir-widget--person--committee member"><span class="nir-widget--person--committee-icon ndqicon__member"></span><a href="/static-files/25717254-e23e-4e81-af2b-0963e84e416e" target="_blank">Member of the Audit Committee</a></div><div class="nir-widget--list-item nir-widget--person--committee member"><span class="nir-widget--person--committee-icon ndqicon__member"></span><a href="/static-files/a4f3ff93-e1e8-4bf7-a6d1-180534cc2fcd" target="_blank">Member of the Compensation and Organisation Committee</a></div> </div> </div> </div><div class="person"> <div class="person__heading"> <img class="person__picture" height="120" src="/static-files/bfe8eb2e-ae08-428c-8d42-ebb437d8e27f" width="120"> <div class="person__details"> <h3>Dr. Linda Grais</h3> <div class="field field--name-field-nir-person-title field--type-string field--label-hidden field__item">Non-Executive Director</div> </div> </div> <div class="person__body"> <div class="field field--name-field-nir-person-bio field--type-text-long field--label-hidden field__item"><p><span style="font-size:10.0pt"><span style="line-height:115%"><span style="font-family:"Arial",sans-serif"><span style="font-size:11.0pt"><span style="background:#fefefe"><span style="line-height:115%"><span style="font-family:"Arial",sans-serif"><span style="color:#575756"><span style="font-size:11.0pt"><span style="background:#fefefe"><span style="line-height:115%"><span style="font-family:"Arial",sans-serif"><span style="color:#575756"><span style="background:#fefefe; font-family:"Arial",sans-serif; font-size:11.0pt; line-height:115%; mso-ansi-language:EN-IE; mso-bidi-language:AR-SA; mso-fareast-font-family:Arial; mso-fareast-language:EN-US; mso-fareast-theme-font:minor-latin"><span style="font-size:11.0pt"><span style="background:#fefefe"><span style="line-height:115%"><span style="font-family:"Arial",sans-serif"><span style="font-size:11.0pt"><span style="background:#fefefe"><span style="line-height:115%"><span style="font-family:"Arial",sans-serif"></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></p> <p style="margin-bottom: 13px;">Dr. Linda Grais has served as a Non-Executive Director of ICON plc since July 2021 having previously served as a member of the PRA Health Sciences board from October 2015 to July 2021. Dr. Grais served as a member of the board of directors of Ocera Therapeutics, Inc. from January 2008 through December 2017 and as President and Chief Executive Officer of Ocera Therapeutics, Inc. from June 2012 to December 2017. Prior to her employment by Ocera, Dr. Grais served as a managing member at InterWest Partners, a venture capital firm from May 2005 until February 2011. From July 1998 to July 2003, Dr. Grais was a founder and executive vice president of SGX Pharmaceuticals Inc., a drug discovery company focusing on new treatments for cancer. Prior to that, she was a corporate attorney at Wilson Sonsini Goodrich & Rosati, where she practiced in such areas as venture financings, public offerings and strategic partnerships. Before practicing law, Dr. Grais worked as an assistant clinical professor of Internal Medicine and Critical Care at the University of California, San Francisco. She currently serves on the boards of directors of Corvus Pharmaceuticals and Arca Biopharma, Inc. and sits on the compensation and audit committees of Arca Biopharma, Inc. and the audit committee of Corvus Pharmaceuticals. Dr. Grais received a B.A. from Yale University, an M.D. from Yale Medical School and a J.D. from Stanford Law School.<span style="font-size:10.0pt"><span style="line-height:115%"><span style="font-family:"Arial",sans-serif"><span style="font-size:11.0pt"><span style="background:#fefefe"><span style="line-height:115%"><span style="font-family:"Arial",sans-serif"><span style="color:#575756"><span style="font-size:11.0pt"><span style="background:#fefefe"><span style="line-height:115%"><span style="font-family:"Arial",sans-serif"><span style="color:#575756"><span style="background:#fefefe; font-family:"Arial",sans-serif; font-size:11.0pt; line-height:115%; mso-ansi-language:EN-IE; mso-bidi-language:AR-SA; mso-fareast-font-family:Arial; mso-fareast-language:EN-US; mso-fareast-theme-font:minor-latin"><span style="font-size:11.0pt"><span style="background:#fefefe"><span style="line-height:115%"><span style="font-family:"Arial",sans-serif"><span style="font-size:11.0pt"><span style="background:#fefefe"><span style="line-height:115%"><span style="font-family:"Arial",sans-serif"></span></span></span></span></span></span></span></span></span> </span></span></span></span></span> </span></span></span></span></span> </span></span></span></p></div> <div class="nir-widget--field nir-widget--person--dir-details"> <div class="nir-widget--list-item nir-widget--person--dir-detail ndqicon__independent">Independent Director</div> </div> <div class="nir-widget--field nir-widget--person--committees"> <div class="nir-widget--list-item nir-widget--person--committee chairperson"><span class="nir-widget--person--committee-icon ndqicon__chairperson"></span><a href="/static-files/a4f3ff93-e1e8-4bf7-a6d1-180534cc2fcd" target="_blank">Chair of the Compensation and Organisation Committee</a></div><div class="nir-widget--list-item nir-widget--person--committee member"><span class="nir-widget--person--committee-icon ndqicon__member"></span><a href="/static-files/99ff596c-3662-4799-b32f-4351318b23b4" target="_blank">Member of the Nominating, Sustainability & Governance Committee </a></div> </div> </div> </div><div class="person"> <div class="person__heading"> <img class="person__picture" height="120" src="/static-files/185b3d6c-f1dd-4b49-80a4-c04456498902" width="120"> <div class="person__details"> <h3>Ms. Anne Whitaker</h3> <div class="field field--name-field-nir-person-title field--type-string field--label-hidden field__item">Non-Executive Director</div> </div> </div> <div class="person__body"> <div class="field field--name-field-nir-person-bio field--type-text-long field--label-hidden field__item"><p>Ms. Anne Whitaker was appointed as a non-executive director of ICON plc in July 2024. </p> <p>Ms. Whitaker is an experienced healthcare executive, advisor and director. Ms. Whitaker currently serves as managing partner of Anne Whitaker Group, LLC, a board and private equity advisory firm and as an Operating Partner of NewVale Capital, a Private Equity firm. Ms. Whitaker was previously CEO and Chair of Aerami Therapeutics, CEO and Director of Novoclem Therapeutics and earlier in her career, Ms. Whitaker held senior executive leadership positions at Bausch Health, Sanofi, GlaxoSmithKline, and multiple CEO roles for private and public development-stage companies.</p> <p>Ms. Whitaker serves as the Chair of QurAlis and as a non-executive director of Nykode Therapeutics, Trinity Life Sciences, Byrn Pharma, Bespak, and is a Member of the Board of Trustees of the University of North Alabama. She previously served on the boards of Curio Digital Therapeutics, Ergomed plc, UDG Healthcare, Cree, Mallinckrodt, KNOW Bio, Novoclem Therapeutics, Vectura Group and Synta Pharmaceuticals. </p> <p>Ms. Whitaker holds a BSc in Chemistry and Business from the University of North Alabama.</p></div> <div class="nir-widget--field nir-widget--person--dir-details"> <div class="nir-widget--list-item nir-widget--person--dir-detail ndqicon__independent">Independent Director</div> </div> <div class="nir-widget--field nir-widget--person--committees"> <div class="nir-widget--list-item nir-widget--person--committee member"><span class="nir-widget--person--committee-icon ndqicon__member"></span><a href="/static-files/99ff596c-3662-4799-b32f-4351318b23b4" target="_blank">Member of the Nominating, Sustainability & Governance Committee </a></div> </div> </div> </div><div class="person"> <div class="person__heading"> <img class="person__picture" height="120" src="/static-files/b8d945bb-e7a3-4d24-ad03-dd9c38c87d89" width="120"> <div class="person__details"> <h3>Mr. Diarmaid Cunningham</h3> <div class="field field--name-field-nir-person-title field--type-string field--label-hidden field__item">Chief Administrative Officer, General Counsel & Company Secretary</div> </div> </div> <div class="person__body"> <div class="field field--name-field-nir-person-bio field--type-text-long field--label-hidden field__item"><p>Mr. Diarmaid Cunningham is Chief Administrative Officer, General Counsel and Company Secretary. </p> <p>Mr. Cunningham joined the Company as General Counsel in November 2009.  From 2009 until 2013, Mr. Cunningham was based in the Company鈥檚 global headquarters in Dublin.  In 2013, Mr. Cunningham was seconded to the Company鈥檚 US headquarters in Pennsylvania and that secondment ended in 2018 when Mr. Cunningham returned to Dublin.</p> <p>In July 2016, Mr. Cunningham鈥檚 role expanded to include Chief Administrative Officer in addition to General Counsel which added responsibility for the Company鈥檚 Quality Assurance, Client Contracts Services, Facilities and Procurement groups in addition to his responsibility for the Company鈥檚 Legal group. In 2023, Symphony Health (ICON's data business) moved to report to Mr. Cunningham and was also added to his group. </p> <p>Mr. Cunningham graduated with a Bachelor of Business and Legal Studies from University College Dublin in 1997, qualified as a lawyer in 2001 and completed the Stanford Executive Program at Stanford University in California in 2015.  Mr. Cunningham served as Secretary to the Board of the Association of Clinical Research Organizations (ACRO) in 2013, 2014, 2020 and 2021. ACRO represents the CRO industry globally to key stakeholders including pharmaceutical, biotech and medical device companies, regulators, legislators and patient groups.</p> <p>Prior to joining the Company, Mr. Cunningham spent 10 years with A&L Goodbody, one of Ireland's premier corporate law firms.</p> <p style="margin-bottom:13px">In January 2021, Mr. Cunningham was appointed as a non-executive director of the Irish charity The Jack & Jill Foundation.</p></div> <div class="nir-widget--field nir-widget--person--committees"> <div class="nir-widget--list-item nir-widget--person--committee member"><span class="nir-widget--person--committee-icon ndqicon__member"></span><a href="/static-files/1459d44f-eb5d-45d5-860f-b98484dd1a29" target="_blank">Member of the Execution Sub-Committee</a></div> </div> </div> </div> </div> </div> </div> </div> </div> </div></div> </div>  </div> </article> </div> </div> <div class="show-in-front"> <br/> <div class="row small-up-1 medium-up-3 large-up-3 shareholder"> </div> </div> <div class="row column"> <hr style="visibility: hidden;" /> </div> <div class="expanded ndq-tools"> <div class="row small-up-3 medium-up-6 large-up-6 "> <div class="column"> <a href="javascript:window.print();" class="ndq-tool-icon ndqicon-print" title="Print Page" aria-label="Print Page"></a> </div> <div class="column"> <a href="#" onclick="window.location='mailto:?subject=' + encodeURIComponent(document.title) + '&body=' + encodeURIComponent(window.location.href); return false;" class="ndq-tool-icon ndqicon-mail" title="Email Page" aria-label="Email Page"></a> </div> <div class="column"> <a href="/email-alerts" class="ndq-tool-icon ndqicon-alerts" title="Email Alerts" aria-label="Email Alerts"></a> </div> <div class="column"> <a href="/download-library" class="ndq-tool-icon ndqicon-downloads-3" title="Download Library" aria-label="Download Library"></a> </div> <div class="column"> <a href="/rss-feeds" class="ndq-tool-icon ndqicon-rss" title="RSS Feeds" aria-label="RSS Feeds"></a> </div> <div class="column"> <a href="/investor-contact" class="ndq-tool-icon ndqicon-mobile" title="Investor Contact" aria-label="Investor Contact"></a> </div> </div> </div> <footer class="footer"> <div class="footer__main-content"> <div class="container-fluid container-fluid--xl"> <div class="row"> <div class="field field--name-field-nir-global-block-body field--type-text-long field--label-hidden field__item"><div class="col-12 col-md-3 global-block-content"> <img alt="ICON plc" class="footer__logo" height="38" src="/sites/g/files/knoqqb32306/themes/site/nir_pid2802/dist/img/ICON_positive_logo.svg" width="138" loading="lazy"> <ul class="footer__nav--primary list-unstyled"> <li> <a href="https://iconplc.com/contact/">Contact</a> </li> <li> <a href="https://iconplc.com/about/">About ICON</a> </li> <li> <a href="/financials-filings/annual-reports">Results & Reports</a> </li> </ul> </div></div> <div class="col-6 col-md-2"> <h6 class="footer__nav-title">For Clients</h6> <ul class="footer__nav--secondary list-unstyled"> <li> <a target="" href="https://iconplc.com/therapeutics/">Therapeutics</a> </li> <li> <a target="" href="https://iconplc.com/services/">Services</a> </li> <li> <a target="" href="https://iconplc.com/insights/">Insights</a> </li> <li> <a target="" href="https://iconplc.com/innovation/">Innovation</a> </li> </ul> </div> <div class="col-6 col-md-2"> <h6 class="footer__nav-title">ICON For</h6> <ul class="footer__nav--secondary list-unstyled"> <li> <a target="" href="https://iconplc.com/investigators/">Investigators</a> </li> <li> <a target="" href="https://iconplc.com/news-events/mediakit/">Mediakit</a> </li> <li> <a target="" href="https://www.iconplc.com/study-volunteers">Volunteers</a> </li> <li> <a target="" href="/investors">Investors</a> </li> <li> <a target="_blank" href="https://careers.iconplc.com/">Jobs & Careers</a> </li> </ul> </div> <div class="col-6 col-md-2"> <h6 class="footer__nav-title">News & Events</h6> <ul class="footer__nav--secondary list-unstyled"> <li> <a target="" href="https://iconplc.com/news-events/press-releases/">Press Releases</a> </li> <li> <a target="" href="https://iconplc.com/news-events/events/">Events</a> </li> <li> <a target="" href="https://iconplc.com/news-events/social-media/">ICON on Social Media</a> </li> </ul> </div> <div class="field field--name-field-nir-global-block-body field--type-text-long field--label-hidden field__item"><div class="col-12 col-md-3 global-block-content"> <ul class="list-social list-inline mb-0 float-md-right"> <li class="list-inline-item"> <a href="https://www.linkedin.com/company/icon-plc-2" title="ICON on LinkedIn" class="linkedin" target="_blank"> <i aria-hidden="true" class="fa fa-linkedin"><span style="display: none !important;"> </span></i> <span class="sr-only">LinkedIn</span> </a> </li> <li class="list-inline-item"> <a href="https://twitter.com/ICONplc" title="ICON on Twitter" class="twitter" target="_blank"> <i aria-hidden="true" class="fa fa-twitter"><span style="display: none !important;"> </span></i> <span class="sr-only">Twitter</span> </a> </li> <li class="list-inline-item"> <a href="https://www.facebook.com/icon.plc.profile" title="ICON on Facebook" class="facebook" target="_blank"> <i aria-hidden="true" class="fa fa-facebook"><span style="display: none !important;"> </span></i> <span class="sr-only">Facebook</span> </a> </li> <li class="list-inline-item"> <a href="https://www.youtube.com/user/ICONPlc" title="ICON on Youtube" class="youtube" target="_blank"> <i aria-hidden="true" class="fa fa-youtube-play"><span style="display: none !important;"> </span></i> <span class="sr-only">Youtube</span> </a> </li> </ul> </div></div> </div> </div> </div> <div class="copyright"> <div class="container-fluid container-fluid--xl"> <ul class="list-inline"> <li class="list-inline-item">漏 2024 ICON plc</li> <li class="list-inline-item"> <a target="" class="" href="https://iconplc.com/disclaimer/">Disclaimer</a> </li> <li class="list-inline-item"> <a target="" class="" href="https://iconplc.com/privacy/">Privacy</a> </li> <li class="list-inline-item"> <a target="" class="" href="https://iconplc.com/site-cookies/">Site Cookies</a> </li> </ul> </div> </div> </footer> <div class="reveal ndq-modal-reveal" id="searchModal" data-reveal=""> <h3>Search Investor</h3> <div id="block-search-2" class="block--search-form block--search-form--5876 block--search-modal--search-form block--search-modal--search-form--5876 block--af27d932-89ac-418f-a954-85b4be1a9437 block--af27d932-89ac-418f-a954-85b4be1a9437--5876 block block-nir-search block-search-form"> <form data-block-uuid="af27d932-89ac-418f-a954-85b4be1a9437" action="/search" method="get" accept-charset="UTF-8"> <div class="js-form-item form-item js-form-type-search form-item-query js-form-item-query form-no-label"> <input type="search" name="query" size="60" maxlength="128" placeholder="Search" class="form-search required" required="required" aria-required="true" /> </div> <input type="submit" name="op" value="Search" class="button button--primary js-form-submit form-submit" /> </form> </div> <button class="close-button" data-close aria-label="Close modal" type="button"> <span aria-hidden="true">脳</span> </button> </div> </div> <script type="text/javascript">var s_CCSWebHostingAccount = "trcgiconplc";</script> <script type="application/json" data-drupal-selector="drupal-settings-json">{"path":{"baseUrl":"\/","pathPrefix":"","currentPath":"node\/5841","currentPathIsAdmin":false,"isFront":false,"currentLanguage":"en"},"pluralDelimiter":"\u0003","suppressDeprecationErrors":true,"ajaxPageState":{"libraries":"eJyVkVFuAyEMRC-0Wqp89Ro9ATJgNdaCHdnetLl9CYmUbtWkjZAAD88DYpg0AkM9OWUL_L2aoUjCWGHlvJ_4T_CgUgaWwHAQlIVtK7lITaBDzAsWctFYwPtIFS3ctgNpoAv6AGKqkpcwbjWPCk783o27zx7U_4VbHN532IbAUTFLa8hdJ-GH3r-q87kduDzVY97nt1X8-rS1OrX-ORC25Tg9UNm9vuyCHFGVyqXlA5ORY2TpieAloB_afF0nhUKfPdeTrG5hU03WPwtbOOf1Ba-y1dg","theme":"nir_pid2802","theme_token":null},"ajaxTrustedUrl":[],"nir_admin_use_chosen":true,"nir_admin_use_select2":false,"user":{"uid":0,"permissionsHash":"94b6679060bd7490dde98f82c94a2284dad1098290ee7bd5ce0dd87566ccadf9"}}</script> <script src="/sites/g/files/knoqqb32306/themes/site/nir_pid2802/dist/js/jquery.js?snc0ge"></script> <script src="/sites/g/files/knoqqb32306/themes/site/nir_pid2802/dist/js/what-input.js?snc0ge"></script> <script src="/sites/g/files/knoqqb32306/themes/site/nir_pid2802/dist/js/foundation.js?snc0ge"></script> <script src="/sites/g/files/knoqqb32306/themes/site/nir_pid2802/dist/js/app.js?snc0ge"></script> <script src="/sites/g/files/knoqqb32306/themes/site/nir_pid2802/dist/js/ndq-functions.js?snc0ge"></script> <script src="/sites/g/files/knoqqb32306/files/js/js_C9_RiwqA93hAA9UvBeB8JuBwVWZz2jrDxIciYXOLddM.js?scope=footer&delta=5&language=en&theme=nir_pid2802&include=eJyVkGFqwzAMhS8U4tFfu0ZPIGRbtCa2VGRla29f1RkbgRZWDLb0-B5-EheFtFAuJgoZzU-s1MNfObEjDXUhGwDEKmkJjZBBKUlrxK4XYUhnVHvBI2O9dQN1lE8QUd_AO4wsG7tWK80TY9i3U3cDtRCxb-SjGExJwn0vmUj1DEO8lHz4_DgE-SLVkmlSzOUKFW-yWg-7bhi-KfZiBCxWki_riTb_vC_Ge6rOj2Ui57c83fw-rmLbzGNv_vMW6rebMUskH2LldP4HeFHJd9S51dg"></script> <script src="/core/assets/vendor/ckeditor5/ckeditor5-dll/ckeditor5-dll.js?v=40.2.0"></script> <script src="/profiles/nasdaqir/modules/custom/nir_ckeditor_datatables/js/build/datatables.js?v=1.10.9"></script> <script src="/sites/g/files/knoqqb32306/files/js/js_qcc42L4fnrl2LvnmSwORDIryQZVV3LFVSmfEqT4FIiI.js?scope=footer&delta=8&language=en&theme=nir_pid2802&include=eJyVkGFqwzAMhS8U4tFfu0ZPIGRbtCa2VGRla29f1RkbgRZWDLb0-B5-EheFtFAuJgoZzU-s1MNfObEjDXUhGwDEKmkJjZBBKUlrxK4XYUhnVHvBI2O9dQN1lE8QUd_AO4wsG7tWK80TY9i3U3cDtRCxb-SjGExJwn0vmUj1DEO8lHz4_DgE-SLVkmlSzOUKFW-yWg-7bhi-KfZiBCxWki_riTb_vC_Ge6rOj2Ui57c83fw-rmLbzGNv_vMW6rebMUskH2LldP4HeFHJd9S51dg"></script> <script src="https://assets.adobedtm.com/898335afd880/c52ee8aa1e90/launch-5ef258dce664.min.js" async integrity="sha384-9QSqHMB+yiy/V4i+d2Au+ydEWbBz4E9DqsE+oYKOnL+kj4XAZGYZxabd0P3OGHkf"></script>  <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-5K68HBC" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>  </body> </html>

CINXE.COM

Board of Directors | ICON plc